Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Povidone-iodine versus metronidazole gel for vaginal antisepsis before emergency cesarean section
IRCT20250225064853N2Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of povidone-iodine and metronidazole in surgical site infection (SSI), Infection and Wound infection (WI) (3 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Wound healing rate, Reduction of infection symptoms and 1 more. Started Mar 2025; status: completed.
02
Drugs
povidone-iodinemetronidazole
03
Conditions
surgical site infection (SSI)InfectionWound infection (WI)
Beyond the preview
Go deeper on IRCT20250225064853N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250225064853N2.